Assignee
PF MEDICAMENT
FR·183 granted patents·80 pending applications·1,814 citations·filing 1985–2025
Top patents by PatentIndex Score
263 records- 0193US7241444B2Anti-IGF-IR antibodies and uses thereofPF MEDICAMENT·Filed 2003·Granted Jul 10, 2007·95 cites·17 claims
- 0292USD421800SPowder and compressed-air inhalerPF MEDICAMENT·Filed 1998·Granted Mar 21, 2000·67 cites·1 claims
- 0391US12312336B2Inhibitors of RAF kinasesPF MEDICAMENT·Filed 2021·Granted May 27, 2025·2 cites·20 claims
- 0491US9011865B2Combination of a c-Met antagonist and an aminoheteroaryl compound for the treatment of cancerPF MEDICAMENT·Filed 2013·Granted Apr 21, 2015·6 cites·17 claims
- 0591US6599540B1Use of a Serenoa repens extract for the production of a medicament to treat prostate cancerPF MEDICAMENT·Filed 2000·Granted Jul 29, 2003·44 cites·6 claims
- 0690US5789412APiperazides derived from arylpiperazine, processes for their preparation, their use as medicaments and pharmaceutical compositions comprising themPF MEDICAMENT·Filed 1995·Granted Aug 4, 1998·92 cites·38 claims
- 0789US7914784B2Anti-IGF-IR antibodies and uses thereofPF MEDICAMENT·Filed 2007·Granted Mar 29, 2011·10 cites·19 claims
- 0888US10633448B2IGF-1R antibody-drug-conjugate and its use for the treatment of cancerPF MEDICAMENT·Filed 2015·Granted Apr 28, 2020·4 cites·21 claims
- 0987US10766959B2Anti-C10ORF54 antibodies and uses thereofPF MEDICAMENT·Filed 2015·Granted Sep 8, 2020·3 cites·15 claims
- 1087US10202458B2IGF-1R antibody and its use as addressing vehicle for the treatment of cancerPF MEDICAMENT·Filed 2015·Granted Feb 12, 2019·9 cites·24 claims
- 1187US8361461B2Anti-IGF-IR antibodies and uses thereofPF MEDICAMENT·Filed 2006·Granted Jan 29, 2013·8 cites·27 claims
- 1287US6149911AMethod for enhancing the immunogenicity of an immunogenic compound or hapten, and use thereof for preparing vaccinesPF MEDICAMENT·Filed 1995·Granted Nov 21, 2000·59 cites·46 claims
- 1386US7854930B2Anti-igf-ir antibodies and uses thereofPF MEDICAMENT·Filed 2005·Granted Dec 21, 2010·7 cites·8 claims
- 1485US11517625B2Antibody-drug-conjugate and its use for the treatment of cancerPF MEDICAMENT·Filed 2020·Granted Dec 6, 2022·1 cites·10 claims
- 1585US11090298B2Method for treating movement disorders with befiradolPF MEDICAMENT·Filed 2019·Granted Aug 17, 2021·2 cites·7 claims
- 1685US10858423B2Composition for the treatment of IGF-1R expressing cancerPF MEDICAMENT·Filed 2016·Granted Dec 8, 2020·3 cites·14 claims
- 1785US7553485B2Anti-IGF-IR and/or anti-insulin/IGF-I hybrid receptors antibodies and uses thereofPF MEDICAMENT·Filed 2004·Granted Jun 30, 2009·18 cites·5 claims
- 1885US6589953B2Indole derivatives as 5-HT1B and 5-HT1D agonistsPF MEDICAMENT·Filed 2001·Granted Jul 8, 2003·20 cites·13 claims
- 1984US11219693B2Antibody-drug-conjugate and its use for the treatment of cancerPF MEDICAMENT·Filed 2019·Granted Jan 11, 2022·1 cites·26 claims
- 2084US7524627B2Method of generating and/or increasing an immune response against RSVPF MEDICAMENT·Filed 2007·Granted Apr 28, 2009·3 cites·7 claims
- 2184US7005452B2Use of the dextrogyral enantiomer of milnacipran for the preparation of a drugPF MEDICAMENT·Filed 2003·Granted Feb 28, 2006·29 cites·22 claims
- 2283US10912841B2Antibody-drug-conjugate and its use for the treatment of cancerPF MEDICAMENT·Filed 2018·Granted Feb 9, 2021·1 cites·17 claims
- 2383US6020345APyridin-2-yl-methylamine derivatives, method of preparing and application as medicinePF MEDICAMENT·Filed 1997·Granted Feb 1, 2000·66 cites·15 claims
- 2483US5034541AMethod of preparing 1-phenyl-1-diethylaminocarbonyl-2-phthalimidomethyl-cyclopropane-zPF MEDICAMENT·Filed 1989·Granted Jul 23, 1991·27 cites·14 claims
- 2583US4959175ASolution for dialyses and use of peptides based on glycine for preparing itPF MEDICAMENT·Filed 1988·Granted Sep 25, 1990·78 cites·7 claims
- 2683US2023406940A1ANTI-cMET ANTIBODYPF MEDICAMENT·Filed 2022·Application pending·0 cites
- 2782US11365259B2IGF-1R antibody and its use as addressing vehicle for the treatment of cancerPF MEDICAMENT·Filed 2018·Granted Jun 21, 2022·2 cites·26 claims
- 2882US10314921B2Antibody-drug-conjugate and its use for the treatment of cancerPF MEDICAMENT·Filed 2015·Granted Jun 11, 2019·3 cites·23 claims
- 2982US7846926B2(Poly)aminoacetamide derivatives of epipodophyllotoxin their process of preparation and their applications in therapeutics as anticancer agentsPF MEDICAMENT·Filed 2005·Granted Dec 7, 2010·5 cites·8 claims
- 3082US5620985AAntimitotic binary alkaloid derivatives from catharanthus roseusPF MEDICAMENT·Filed 1994·Granted Apr 15, 1997·55 cites·13 claims
- 3182US5132116ATablets of the hydrophilic matrix type based on salbutamol and a process for their preparationPF MEDICAMENT·Filed 1991·Granted Jul 21, 1992·53 cites·18 claims
- 3282US2025025383A1Emollient composition in emulsion formPF MEDICAMENT·Filed 2024·Application pending·0 cites
- 3381US8034377B2DHA esters and use thereof in treatment and prevention of cardiovascular diseasePF MEDICAMENT·Filed 2007·Granted Oct 11, 2011·7 cites·13 claims
- 3481US5591743A3,5-dioxo-(2H,4H)-1,2,4-triazine derivatives as 5HT1A ligandsPF MEDICAMENT·Filed 1994·Granted Jan 7, 1997·49 cites·12 claims
- 3580US2023002316A1Derivatives of dolastatin 10 and auristatinsPF MEDICAMENT·Filed 2022·Application pending·0 cites
- 3679US7309494B2Peptides of the respiratory syncytial virus (RSV) G protein and their use in a vaccinePF MEDICAMENT·Filed 2002·Granted Dec 18, 2007·12 cites·5 claims
- 3779US6113911APeptide fragment of respiratory syncytial virus protein G, immunogenic agent, pharmaceutical composition containing it and preparation methodPF MEDICAMENT·Filed 1995·Granted Sep 5, 2000·37 cites·2 claims
- 3878US5977106A3,5-dioxo-(2H,4H)-1,2,4-triazine derivativesPF MEDICAMENT·Filed 1995·Granted Nov 2, 1999·51 cites·5 claims
- 3977US7932406B2Method for preparing 4β-amino-4′-demethyl-4-desoxypodophyllotoxinPF MEDICAMENT·Filed 2006·Granted Apr 26, 2011·2 cites·9 claims
- 4077USD576799SInterproximal brushPF MEDICAMENT·Filed 2008·Granted Sep 16, 2008·22 cites·1 claims
- 4177US7220545B2Peptide fragment of respiratory syncytial virus protein G, immunogenic agent, pharmaceutical composition containing it and preparation methodPF MEDICAMENT·Filed 2003·Granted May 22, 2007·8 cites·6 claims
- 4277US7018648B2Transdermal device for administering testosterone or one of the derivatives thereofPF MEDICAMENT·Filed 2000·Granted Mar 28, 2006·10 cites·26 claims
- 4376US11918656B2Antibody-drug-conjugate and its use for the treatment of cancerPF MEDICAMENT·Filed 2021·Granted Mar 5, 2024·0 cites·11 claims
- 4476US6699506B1Pharmaceutical composition with extended release of MilnacipranPF MEDICAMENT·Filed 1997·Granted Mar 2, 2004·45 cites·37 claims
- 4576US5288758ANew urea derivatives, their preparation and their application in therapyPF MEDICAMENT·Filed 1992·Granted Feb 22, 1994·17 cites·7 claims
- 4675US10548885B2Method for treating movement disorders with befiradolPF MEDICAMENT·Filed 2015·Granted Feb 4, 2020·2 cites·17 claims
- 4775US10457734B2IGF-1R antibody and its use for the diagnosis of cancerPF MEDICAMENT·Filed 2016·Granted Oct 29, 2019·2 cites·24 claims
- 4875US10047064B2Flavagline derivativesPF MEDICAMENT·Filed 2015·Granted Aug 14, 2018·2 cites·12 claims
- 4975US7456192B23β-amino azabicyclooctane heteroaromatic amid derivatives preparation method and therapeutic uses thereofPF MEDICAMENT·Filed 2002·Granted Nov 25, 2008·9 cites·10 claims
- 5075US6410030B1Peptide fragment of respiratory syncytial virus protein G, immunogenic agent, pharmaceutical composition containing it and preparation processPF MEDICAMENT·Filed 2000·Granted Jun 25, 2002·7 cites·2 claims
Showing the top 50 of 263 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →